Specialising in haematological malignancies (leukaemias, lymphomas and myelomas) we work closely with the NHS to answer key questions of public and scientific concern that cannot be addressed elsewhere.
Unlike most other cancers, haematological cancers can affect people at any age, from birth through to old age. Our research captures the health experiences of the general population and spans the full spectrum of epidemiology – from disease causes through to their consequences.
We inform researchers, clinicians, patients and the public about the characteristics and outcomes of patients with cancer and our unique datasets yield relevant national and international evidence.
Our unique real-time clinical data, supplemented by information about experiences from patients, family members and clinicians, enables essential collaborations. We harness the power of these collaborations to answer the fundamental questions that we have about cancer and how it affects us.